How employers can prioritize women’s health in benefits plans
Amid a wave of frank and open discussions about women’s health, more plan sponsors are beginning to review their benefits and human resources policies with…
Amid a wave of frank and open discussions about women’s health, more plan sponsors are beginning to review their benefits and human resources policies with…
For nearly 10 years, Benefits Canada’s Chronic Disease at Work conference has examined the current trends in chronic disease in Canada and what they mean for plan…
Employers can support employees going through menopause by improving their workplace culture, communication and accommodation policies and employee benefits, said Janet Ko, president and co-founder of…
After her husband Mike Kessler was diagnosed with mild Alzheimer’s disease in 2021, Karen Kessler admitted she would hover around him. The Windsor, Ont. couple…
Employees with pulmonary arterial hypertension can experience significant impacts to their quality of life and workplace experience, said John Granton, a respirologist with the University…
With the increased availability of treatments for inflammatory bowel disease, patients can achieve longer periods of remission, said Vipul Jairath, a gastroenterologist at the London…
The “most widely anticipated recession in history” could arrive in 2024, said Eric Lascelles, chief economist at RBC Global Asset Management, during the keynote session…
On Dec. 6, the Canadian Investment Review hosted its annual Defined Benefit Investment Forum. With the close of a year marred by financial fragility and global…
Multi-family real estate is set up for long-term sustained returns given the extreme dislocation between housing supply and demand in Canada and record-high federal immigration…
A quality investing strategy has some of the same benefits of a well-made pair of sneakers, said Ranjit Sufi, managing director and head of institutional…
After the simultaneous sell-off of both equities and bonds in the first half of 2022, many defined benefit pension plan sponsors were forced to “pay…
With historic perceptions of emerging markets and equities no longer matching reality, institutional investors have the opportunity to scoop up good companies at low valuations,…
Pension plan sponsors must effectively employ care, diligence and skill when facing cybersecurity threats, said Sandeep Kakan, board trustee and secretary at the Canada-Wide Industrial…
On Dec. 5, 2023, Benefits Canada held its annual Face to Face Drug Plan Management Forum, the industry’s most popular drug benefits conference. Industry experts…
A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director…
Many plan members with diabetes struggle with adherence to daily insulin injections and research has found the majority of patients wish they could achieve the…
Pharmacists are now uniquely positioned to support Canadians at a time when the public health-care system is stretched thin, creating significant barriers for people looking…
Many Canadians living with asthma are experiencing poor control over their symptoms, impacting the workplace, said Anjila Arora, director of pharmaceutical benefits at Sun Life…
With chronic conditions growing in prevalence among plan members, plan sponsors have their work cut out for them in designing benefits plans that provide adequate…
While medications for three interconnected chronic conditions — cardiovascular disease, diabetes and obesity — represent a growing proportion of employers’ drug spend, there’s plenty that…
Despite the safety and efficacy of biosimilars — and the potential cost savings they offer — uptake among private payers has been low historically and is only starting to…
It’s important for private payers and employers to be nimble and innovative to support plan members seeking access to novel drugs and treatments by addressing…
Innovations in medical technology in the next 10 years could unlock a new dawn of health investments that will make the last decade look slow…
Institutional investors are preparing for a bumpy return risk space where volatility is higher for all assets and real returns are much lower than what…